A metal-polyphenol nanomaterial, its preparation method and application

By preparing manganese-based coordination nanosheets and combining them with polyphenol-like compounds, the problem of separating imaging and treatment in IBD using existing MRI contrast materials was solved, achieving simultaneous effects of MRI signal enhancement and reactive oxygen species scavenging, and providing a new diagnostic and therapeutic material.

CN123059079APending Publication Date: 2026-11-10JILIN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611588872.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-10-14
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing MRI contrast materials are difficult to simultaneously achieve imaging enhancement and antioxidant and anti-inflammatory functions in the diagnosis and treatment of IBD. There is a lack of materials that can simultaneously enhance the MRI signal of inflamed intestinal segments and remove reactive oxygen species.

Method used

Manganese-based coordination nanosheets were prepared by hydrothermal reaction and combined with polyphenol-like compounds to prepare metal-polyphenol-like nanomaterials with MRI enhancement and reactive oxygen species scavenging functions. By utilizing the paramagnetic properties of manganese ions and the antioxidant properties of polyphenols, the material can achieve simultaneous imaging and therapeutic effects.

Benefits of technology

It achieves MRI signal enhancement, reduces oxidative stress levels at the site of inflammation, and provides a new material option for simultaneous imaging evaluation and therapeutic intervention.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123059079A_ABST
    Figure CN123059079A_ABST
Patent Text Reader

Abstract

This invention relates to the field of biomedical technology, providing a metal-polyphenol nanomaterial, its preparation method, and its applications. Based on sheet-like nanomaterials formed by the coordination of manganese ions and HHTP, tannic acid is introduced, and ultrasonic disruption gradually transforms the original sheet-like structure into small-sized, dispersed dot-like nanostructures, thereby obtaining dot-like metal-polyphenol nanomaterials. This invention integrates MRI enhancement with antioxidant and anti-inflammatory functions into the same metal-polyphenol nanomaterial system, thus integrating the treatment of inflammatory bowel disease with magnetic resonance imaging evaluation into a single material system, providing a new technical solution for the integrated diagnosis and treatment of inflammatory bowel disease.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biomedical technology, and in particular relates to a metal-like polyphenol nanomaterial, its preparation method and application. Background Technology

[0002] Inflammatory bowel disease (IBD), primarily including ulcerative colitis and Crohn's disease, is characterized by a prolonged course and recurrent flare-ups. Long-term evaluation of the extent of lesions and the degree of inflammatory activity is necessary, along with adjustments to the treatment plan based on changes in the condition. Endoscopy allows direct observation of the intestinal mucosa but is invasive and not suitable for frequent examinations. Magnetic resonance imaging (MRI), on the other hand, offers advantages such as no ionizing radiation, high soft tissue resolution, and the ability to perform multi-parameter imaging, making it suitable for non-invasive evaluation of intestinal lesions. Therefore, further improving the MRI results for inflamed intestinal segments is of great significance for the diagnosis and monitoring of IBD treatment efficacy.

[0003] Current MRI contrast materials are primarily used to alter the signal of tissues or intestinal tracts to improve the contrast between the lesion area and surrounding tissues; their function is generally limited to imaging diagnosis. Treatment of IBD mainly relies on anti-inflammatory drugs, immunosuppressants, and biologics, requiring a separate treatment plan to be developed and implemented after imaging examinations. Diagnosis and treatment are separated, making it difficult to simultaneously intervene in the inflammatory microenvironment of the lesion site during imaging. IBD-affected intestinal segments are often accompanied by excessive production of reactive oxygen species and elevated oxidative stress levels, which further exacerbate the inflammatory response, intestinal mucosal damage, and barrier function abnormalities. Therefore, if orally administered contrast materials could enhance the MRI signal of inflamed intestinal segments while simultaneously clearing reactive oxygen species and alleviating local inflammation, it would facilitate the integration of disease imaging evaluation and therapeutic intervention.

[0004] Existing oral intestinal imaging materials primarily focus on imaging capabilities, while nanomaterials used for IBD treatment mainly aim for drug delivery, anti-oxidation, or anti-inflammation. Materials that can simultaneously enhance MRI and treat the disease are still relatively rare. Combining imaging functionality with antioxidant and anti-inflammatory properties within the same material system is a challenge in the development of diagnostic and therapeutic materials for inflammatory bowel disease. Therefore, it is necessary to develop a metal-polyphenol nanomaterial that can enhance MRI of inflamed intestinal segments and alleviate colitis by scavenging reactive oxygen species and reducing oxidative stress. Summary of the Invention

[0005] The purpose of this invention is to provide a metal-like polyphenol nanomaterial, its preparation method, and its application, in order to solve the problems mentioned in the background art.

[0006] To achieve the above objectives, the present invention provides the following technical solution:

[0007] On one hand, the present invention provides a method for preparing metal-like polyphenol nanomaterials, comprising the following steps:

[0008] Step 1: Mix 5-20 mM manganese salt aqueous solution with 5-30 mg / mL alcohol solution of polyhydroxy aromatic ligand at a volume ratio of 6-10:1 and sonicate. Transfer the resulting mixture to a reaction vessel with a polytetrafluoroethylene liner for hydrothermal reaction. After the reaction is completed, collect the product by centrifugation, wash and freeze-dry to obtain manganese-based coordination nanosheets.

[0009] Step 2: Add the manganese-based coordination nanosheets obtained in Step 1 to deionized water and disperse them evenly to obtain a precursor aqueous dispersion with a concentration of 0.5–2.0 mg / mL; mix the aqueous solution of the polyphenol-like compound with a concentration of 0.25–1.0 mg / mL with the precursor aqueous dispersion at a volume ratio of 1:0.5–2, and sonicate the resulting mixture; after sonication, centrifuge and collect the supernatant containing nanodots; dialyze and freeze-dry the supernatant sequentially to obtain the metal-polyphenol-like nanomaterial.

[0010] On the other hand, the present invention provides a metal-like polyphenol nanomaterial, which is prepared by the above-described preparation method. The metal-like polyphenol nanomaterial includes a nanostructure formed by coordination of manganese ions with a polyhydroxy aromatic ligand and a polyphenol-like compound bound to the nanostructure.

[0011] On the other hand, the present invention provides an application of the above-mentioned metal-polyphenol nanomaterials in the preparation of contrast agents to enhance magnetic resonance imaging of inflammatory diseases.

[0012] On the other hand, the present invention provides an application of the above-mentioned metal-like polyphenol nanomaterials in the preparation of drugs for treating inflammatory diseases.

[0013] Compared with the prior art, the specific beneficial effects of the present invention are as follows:

[0014] This invention prepares manganese-based coordination nanosheets via a hydrothermal reaction, then introduces a polyphenol-like compound followed by ultrasonic disruption, centrifugation, dialysis, and freeze-drying to obtain a metal-polyphenol-like nanomaterial. The manganese ions in the resulting material exhibit paramagnetic properties, influencing the longitudinal relaxation process of surrounding water molecules, thereby shortening the T1 relaxation time and enhancing the T1-weighted magnetic resonance imaging signal, thus giving the material MRI enhancement capabilities. Simultaneously, the manganese-based coordination nanosheets (Mn-HHTP) themselves possess a certain reactive oxygen species (ROS) scavenging ability. Further introduction of tannic acid with abundant polyphenolic hydroxyl groups further enhances the material's free radical and ROS scavenging effects, thereby reducing oxidative stress levels at inflamed sites and exerting antioxidant and intestinal inflammation-relieving effects. This invention combines MRI enhancement and inflammatory bowel disease (IBD) treatment functions into the same nanomaterial system, providing a new material option for the imaging evaluation and treatment of IBD. Attached Figure Description

[0015] Figure 1 The figures show the morphological characterization results of the manganese-based coordination nanosheets prepared in Example 1 of the present invention. A is a scanning electron microscope (SEM) image of the manganese-based coordination nanosheets, and B is a transmission electron microscope (TEM) image of the manganese-based coordination nanosheets.

[0016] Figure 2 The images show the transmission electron microscopy (TEM) characterization results of the manganese-based coordination nanosheets prepared in Example 1 of this invention, which were then ultrasonically broken to form metal-polyphenol-like nanomaterials (MT NDs). A is the TEM image of the material under different ultrasonic treatment times (0, 2, 4, 6, 9 and 12 h), and B is the TEM image of the finally obtained MT NDs.

[0017] Figure 3 The characterization results of the material prepared in Example 1 of this invention are shown in Figure A, which is X-ray photoelectron spectroscopy (XPS), Figure B is X-ray diffraction (XRD) characterization result diagram, Figure C is Fourier transform infrared spectrum (FTIR), and Figure D is Raman spectrum.

[0018] Figure 4 The figure shows the experimental results of scavenging 2,2-diphenyl-1-picrylhydrazine (DPPH) free radicals by the metal-polyphenol nanomaterials prepared in Example 1 of the present invention at different concentrations. A shows the color change and free radical scavenging rate of the DPPH solution after the treatment with different concentrations of materials, and B shows the ultraviolet-visible absorption spectrum of the DPPH solution after the treatment with different concentrations of materials.

[0019] Figure 5 This is a diagram showing the blood compatibility test results of the metal-polyphenol nanomaterials prepared in Example 1 of this invention;

[0020] Figure 6The images show grayscale and pseudocolor images of the metal-polyphenol nanomaterials prepared in Example 1 of this invention under different concentrations and different hydrogen peroxide conditions, obtained by in vitro T1-weighted magnetic resonance imaging.

[0021] Figure 7 The images shown are in vivo magnetic resonance imaging results of the metal-polyphenol nanomaterials prepared in Example 1 of this invention. A is a schematic diagram of the experimental procedure, B is a T1-weighted MRI pseudocolor image of the normal group after oral administration of water, C is a T1-weighted MRI pseudocolor image of the normal group after oral administration of metal-polyphenol nanomaterials, and D is a T1-weighted MRI pseudocolor image of the inflammatory bowel disease model group after oral administration of metal-polyphenol nanomaterials.

[0022] Figure 8 The figure shows the experimental results of treating DSS-induced inflammatory bowel disease mice with the metal-polyphenol nanomaterials prepared in Example 1 of this invention. Detailed Implementation

[0023] To make the objectives, technical solutions, and advantages of this invention clearer, the invention will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative and not intended to limit the invention.

[0024] The specific implementation of the present invention will be described in detail below with reference to specific embodiments.

[0025] Example 1: A metal-polyphenol nanomaterial, the preparation method of which includes the following steps:

[0026] Step 1: 16 mL of 10 mM manganese acetate tetrahydrate aqueous solution was mixed with 2 mL of 14 mg / mL 2,3,6,7,10,11-hexahydroxytriphenylene (HHTP) isopropanol solution. After sonication for 5 min, the mixture was transferred to a reaction vessel with a polytetrafluoroethylene liner and hydrothermally reacted at 85 °C for 12 h. After the reaction was completed, the product was collected by centrifugation and washed successively with N,N-dimethylformamide, ethanol and deionized water. The product was then freeze-dried to obtain manganese-based coordination nanosheets (Mn-HHTP).

[0027] Step 2: Redisperse manganese-based coordination nanosheets in deionized water to prepare a precursor aqueous dispersion with a concentration of 1 mg / mL. Take 30 mL of the precursor aqueous dispersion and mix it with 30 mL of tannic acid (TA) aqueous solution with a concentration of 0.5 mg / mL. Treat the mixture with an ultrasonic cell disruptor with a power of 200 W for 12 h. Centrifuge to collect the supernatant containing small-sized nanomaterials, dialyze overnight and freeze dry to obtain metal-polyphenol nanomaterials (MT NDs).

[0028] Characterization and performance testing;

[0029] The morphology and microstructure of the manganese-based coordination nanosheets prepared in step 1 were characterized by scanning electron microscopy (SEM) and transmission electron microscopy (TEM), such as... Figure 1 As shown in Figure A, SEM observations reveal that the obtained material exhibits an overall polyhedral morphology, with some structures displaying lamellar stacking characteristics, such as... Figure 1 As shown in Figure B, TEM further observed that the material has a relatively clear two-dimensional sheet structure with a certain degree of overlap between the sheets and relatively clear edge contours. The above results indicate that Example 1 successfully prepared a manganese-based coordination nanomaterial with obvious nanosheet structure characteristics.

[0030] Referring to step 2, the ultrasonic disruption time in step 2 was changed, and the resulting samples were observed using a transmission electron microscope (TEM). The results are as follows: Figure 2 As shown in Figure A, at 0 h, the material mainly exhibits a relatively complete sheet-like structure. With the extension of ultrasonic treatment time to 2 h, 4 h, 6 h, 9 h, and 12 h, the material gradually breaks down, the sheet-like outline weakens, the particle size gradually decreases, and it gradually transforms into more dispersed fine particles. This indicates that ultrasonic treatment can effectively disrupt the original manganese-based coordination nanosheet structure and promote its transformation into smaller nanodots. Figure 2 As shown in Figure B, the MT NDs finally obtained in Example 1 exhibit a relatively uniformly dispersed nano-dot morphology, which is consistent with... Figure 1 Compared to the manganese-based coordination nanosheets shown, the material size was significantly reduced after ultrasonic fragmentation, indicating that ultrasonic fragmentation can successfully transform manganese-based coordination nanosheets into dot-like metal-polyphenol nanomaterials MT NDs.

[0031] X-ray photoelectron spectroscopy analysis was performed on the material prepared in Example 1, and the results are as follows: Figure 3 As shown in Figure A, both Mn-HHTP and MT NDs exhibit the characteristic peak of Mn 2p, indicating that the coordination environment around Mn changes after the introduction of tannic acid. This provides a basis for the formation of metal-polyphenol nanomaterials. Figure 3 As shown in Figure B, compared with HHTP, the diffraction peaks and peak shapes of Mn-HHTP and MT NDs changed, indicating that the coordination reaction and ultrasonic treatment altered the structural characteristics of the materials. Fourier transform infrared spectroscopy analysis of the obtained materials yielded the following results: Figure 3 As shown in Figure C, absorption characteristics related to O—H, C=O, C=C, C—O, C—O—C, and Mn—O can be observed in MT NDs, indicating that the material contains manganese-based coordination structures and polyphenolic components. Raman spectroscopy analysis of the obtained material yielded the following results: Figure 3As shown in Figure D, vibrational characteristics related to C—O, C=C, and Mn—O can be observed in MT NDs, further demonstrating that metal-like polyphenol nanomaterials were successfully prepared in Example 1.

[0032] Performance Analysis:

[0033] The metal-polyphenol nanomaterials prepared in Example 1 were configured at different concentrations of 0, 0.625, 1.25, 2.5, 5, and 10 μg / mL, mixed with DPPH free radical solution, and treated in the dark for 2 h. The solution color was observed, and the UV-Vis absorption spectrum was measured. Figure 4 As shown in Figure A, with increasing material concentration, the color of the DPPH solution gradually lightens, and the free radical scavenging rate gradually increases. Figure 4 As shown in Figure B, the UV-Vis absorption spectroscopy results show that, with increasing material concentration, the absorbance increases with increasing MT NDs concentration within the indicated wavelength range. These results indicate that the material provided in this embodiment of the invention has good DPPH free radical scavenging ability, which can provide a basis for reducing inflammation-related oxidative stress.

[0034] The metal-polyphenol nanomaterials prepared in Example 1 were subjected to a hemolytic anemia test, with deionized water as a positive control and 0.9% sodium chloride solution (physiological saline) as a negative control. The material concentrations were 12.5, 25, 50, 100, and 200 μg / mL, respectively. The results are as follows: Figure 5 As shown, no obvious hemolysis was observed in any of the material groups at different concentrations, indicating that the material has good blood compatibility and biocompatibility within the tested concentration range.

[0035] Example 2: Application of metal-polyphenol nanomaterials in contrast agents for enhancing magnetic resonance imaging in inflammatory diseases (inflammatory bowel disease):

[0036] Given that inflammatory sites are often accompanied by elevated ROS levels, hydrogen peroxide (H2O2) was used to simulate the oxidative environment of the inflammatory site. The metal-polyphenol nanomaterials from Example 1 were formulated at different concentrations of 0, 0.05, 0.10, 0.15, and 0.20 mM, and in vitro T1-weighted magnetic resonance imaging was performed under conditions containing 0 mM and 1 mM H2O2, respectively. The results are as follows: Figure 6 As shown, the T1-weighted MRI signal gradually increases with increasing material concentration; at the same material concentration, the MRI signal of the group containing 1 mM H2O2 is stronger, indicating that the material provided in this embodiment of the invention has concentration-dependent T1-weighted MRI enhancement capability and can produce more obvious imaging enhancement effect in an oxidizing environment with high ROS level.

[0037] A mouse model of inflammatory bowel disease was further established by inducing the use of dextran sulfate sodium (DSS), and then... Figure 7 The in vivo magnetic resonance imaging experiment was performed according to the procedure shown in A. Metal-polyphenol nanomaterials (MT NDs) at a concentration of 200 μg / mL were orally administered to normal mice and model mice at a volume of 400 μL per mouse, and T1-weighted imaging was performed using a 3.0 T magnetic resonance imaging device; Figure 7 As shown in Figure B, the MRI signal in the intestinal region of normal mice was relatively weak after oral administration of water; Figure 7 As shown in Figure C, after normal mice were orally administered MT NDs, the T1-weighted signal in the intestinal region was significantly enhanced; Figure 7 As shown in Figure D, after oral administration of MT NDs to mice with inflammatory bowel disease, the intestinal region also showed obvious MRI enhancement signals, and the overall enhancement was more significant than that of normal mice. The above results indicate that the material provided in this embodiment of the invention has good in vivo intestinal T1-weighted MRI enhancement ability and can be used for magnetic resonance imaging evaluation of intestinal lesions related to inflammatory bowel disease.

[0038] Example 3: Application of metal-polyphenol nanomaterials in drugs for treating inflammatory diseases (inflammatory bowel disease):

[0039] A mouse model of inflammatory bowel disease was established using DSS induction. A normal control group, a model group, and a treatment group treated with a combination of DSS and the metal-polyphenol nanomaterials described in Example 1 were established (the model mice were orally administered the metal-polyphenol nanomaterials at a dose of 20 mg / kg for 8 consecutive days). Subsequently, colon tissue was collected for hematoxylin-eosin (H&E) staining and dihydroethidium (DHE) fluorescence staining. The results are as follows: Figure 8 As shown, the colonic tissue structure of mice in the DSS model group was disordered, with damaged mucosal epithelium and significant inflammatory cell infiltration. DHE staining showed a strong fluorescence signal, indicating an increased level of oxidative stress in the colonic tissue. Compared with the DSS model group, the colonic mucosal structure of the metal-polyphenol nanomaterial treatment group was more intact, with reduced tissue damage and inflammatory cell infiltration, and a decreased DHE fluorescence signal. The above results indicate that the material provided in this embodiment can alleviate DSS-induced colonic tissue damage in mice and reduce the level of oxidative stress in the colonic tissue, and has the potential for treatment of inflammatory bowel disease.

[0040] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, and improvements made within the spirit and principles of the present invention should be included within the protection scope of the present invention.

Claims

1. A method for preparing a metal-like polyphenol nanomaterial, characterized in that, Includes the following steps: Step 1: Mix 5-20 mM manganese salt aqueous solution with 5-30 mg / mL alcohol solution of polyhydroxy aromatic ligand at a volume ratio of 6-10:1 and sonicate. Transfer the resulting mixture to a reaction vessel with a polytetrafluoroethylene liner for hydrothermal reaction. After the reaction is completed, collect the product by centrifugation, wash and freeze-dry to obtain manganese-based coordination nanosheets. Step 2: Add the manganese-based coordination nanosheets obtained in Step 1 to deionized water and disperse them evenly to obtain a precursor aqueous dispersion with a concentration of 0.5–2.0 mg / mL; mix the aqueous solution of the polyphenol-like compound with a concentration of 0.25–1.0 mg / mL with the precursor aqueous dispersion at a volume ratio of 1:0.5–2, and sonicate the resulting mixture; after sonication, centrifuge and collect the supernatant containing nanodots; dialyze and freeze-dry the supernatant sequentially to obtain the metal-polyphenol-like nanomaterial.

2. The method for preparing metal-polyphenol nanomaterials according to claim 1, characterized in that, In step 1, the manganese salt aqueous solution is a manganese acetate tetrahydrate aqueous solution; The alcoholic solution of the polyhydroxy aromatic ligand is a 2,3,6,7,10,11-hexahydroxytriphenylisopropanol solution.

3. The method for preparing metal-polyphenol nanomaterials according to claim 1, characterized in that, In step 1, the hydrothermal reaction is carried out at a temperature of 70–100 °C for 8–18 h.

4. The method for preparing metal-polyphenol nanomaterials according to claim 1, characterized in that, In step 2, the aqueous solution of the polyphenol-like compound is an aqueous solution of tannic acid.

5. The method for preparing metal-polyphenol nanomaterials according to claim 1, characterized in that, In step 2, the power of the ultrasonic treatment is 100-300 W, and the time is 6-18 h.

6. A metal-like polyphenol nanomaterial, characterized in that, It is prepared by any one of the preparation methods described in claims 1-5, wherein the metal-polyphenol nanomaterial comprises a nanostructure formed by coordination of manganese ions with polyhydroxy aromatic ligands and a polyphenol compound bound to the nanostructure.

7. The use of the metal-polyphenol nanomaterial as described in claim 6 in the preparation of a contrast agent for enhancing magnetic resonance imaging in inflammatory diseases.

8. The application according to claim 7, characterized in that, The inflammatory disease mentioned is inflammatory bowel disease.

9. The use of the metal-polyphenol nanomaterial as described in claim 6 in the preparation of a drug for treating inflammatory diseases.

10. The application according to claim 9, characterized in that, The inflammatory disease mentioned is inflammatory bowel disease.